Skip To Main Content { "isEditMode": false, "isPublic": true, "context": "", "site": "campus-sanofi-tr", "currentLocale": "tr_TR", "translationsPath": "" } [{ device: /(tablet|ipad|playbook|silk)|(android(?!.*mobi))/i.test(navigator.userAgent) ? 'tablet' : (/Mobile|iP(hone|od)|Android|BlackBerry|IEMobile|Kindle|Silk-Accelerated|(hpw|web)OS|Opera M(obi|ini)/.test(navigator.userAgent) ? 'mobile' : 'desktop'),platform: `magnolia`,language: `tr`,siteType: `advise`,brandWebsiteType: `multibrand`,brandCluster: `multibrand`,subBrandCluster: `multibrand`,region: `emea`,country: `turkey`,target: `hcp`,brand: `Clexane`,gbu: `GBU - General medicines`,franchise: `CV&T - CORE`,therapeutic_area: `CARDIOLOGY`,pageName: `VTE Risk Değerlendirmesi: Prof.Joseph A.Caprini`,indication: `null`,indication_id: `null`,specialty: `Cardiology` }] Türkiye'deki sağlık mesleği mensupları için hazırlanmıştır.
-
-
-
{ event: "article_read", name: `VTE Risk Değerlendirmesi: Prof.Joseph A.Caprini`, author: ``, tags: `İzle`, publication_date: ``, interaction_type: "content" }
VTE Risk Değerlendirmesi: Prof.Joseph A.Caprini
.jpg/jcr:content/Cohen1600x1200+1%20(1).jpg)